Using PrognoScan (http://www.abren.net/PrognoScan/) we found that high ATP7B expression is a poor prognosis index in several neoplasms which non-platina base chemotherapy are applied as standard protocol for: AML (data set GSE8970: P<0.014613), DLBCL (data set E-TABM-346: p<0.026222), follicular lymphoma (data set GSE16131-GPL97: p<0.040192), glioma (data set GSE4412-GPL97: P<0.005900). Here, ATP7B is linked to glioma.